Blood–Brain Barrier Conquest in Glioblastoma Nanomedicine: Strategies, Clinical Advances, and Emerging Challenges
Cancers · 27.09.2024 · 16 (19) · 3300
DOI: 10.3390/cancers16193300 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 27.09.2024. Verfasst von Mengyun Duan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Imaging, Health Science Center, Yangtze University, Jingzhou 434023, China. Die Arbeit wurde bisher 70-mal zitiert (Crossref) und nennt 146 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nature Science Foundation of Hubei Province , Hubei provincial teaching reform research project, Singapore Ministry of Health’s National Medical Research Council, National Research Foundation, Singapore.
Abstract (Originalsprache)
Glioblastoma (GBM) is a prevalent type of malignancy within the central nervous system (CNS) that is associated with a poor prognosis. The standard treatment for GBM includes the surgical resection of the tumor, followed by radiotherapy and chemotherapy; yet, despite these interventions, overall treatment outcomes remain suboptimal. The blood–brain barrier (BBB), which plays a crucial role in maintaining the stability of brain tissue under normal physiological conditions of the CNS, also poses a significant obstacle to the effective delivery of therapeutic agents to GBMs. Recent preclinical studies have demonstrated that nanomedicine delivery systems (NDDSs) offer promising results, demonstrating both effective GBM targeting and safety, thereby presenting a potential solution for targeted drug delivery. In this review, we first explore the various strategies employed in preclinical studies to overcome the BBB for drug delivery. Subsequently, the results of the clinical translation of NDDSs are summarized, highlighting the progress made. Finally, we discuss potential strategies for advancing the development of NDDSs and accelerating their translational research through well-designed clinical trials in GBM therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Imaging, Health Science Center, Yangtze University, Jingzhou 434023, China.
- Department of Anesthesiology, Maternal and Child Health Hospital of Hubei Province, Wuhan 430070, China.
- Department of Radiology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
- Department of Pharmacology, Health Science Center, Yangtze University, Jingzhou 434023, China.
- NUS Center for Cancer Research (N2CR), Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117599, Singapore.
- Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117600, Singapore.
ORCID-Profile: Mengyun Duan, Lian Liu
Förderung
- Nature Science Foundation of Hubei Province , Hubei provincial teaching reform research project
- Singapore Ministry of Health’s National Medical Research Council
- National Research Foundation, Singapore
- Singapore Ministry of Education under its Research Centers of Excellence initiatives (Boon-Cher Goh)
- NUS Center for Cancer Research (N2CR)
- Cancer Programme under Translational Research Programmes (TRPs)
- Yong Loo Lin School of Medicine
- NUS
Zitieren
APA
Duan, M., Cao, R., Yang, Y., Chen, X., Liu, L., Ren, B., Wang, L., & Goh, B. C. (2024). Blood–Brain Barrier Conquest in Glioblastoma Nanomedicine: Strategies, Clinical Advances, and Emerging Challenges. Cancers, 16(19), 3300. https://doi.org/10.3390/cancers16193300
Vancouver
Duan M, Cao R, Yang Y, Chen X, Liu L, Ren B, et al. Blood–Brain Barrier Conquest in Glioblastoma Nanomedicine: Strategies, Clinical Advances, and Emerging Challenges. Cancers. 2024;16(19):3300. doi:10.3390/cancers16193300
BibTeX
@article{Duan2024,
author = {Duan, Mengyun and Cao, Ruina and Yang, Yuan and Chen, Xiaoguang and Liu, Lian and Ren, Boxu and Wang, Lingzhi and Goh, Boon-Cher},
title = {Blood–Brain Barrier Conquest in Glioblastoma Nanomedicine: Strategies, Clinical Advances, and Emerging Challenges},
journal = {Cancers},
year = {2024},
volume = {16},
number = {19},
pages = {3300},
doi = {10.3390/cancers16193300}
}
EUVIMED